Frida Kasteng

557 total citations
22 papers, 395 citations indexed

About

Frida Kasteng is a scholar working on Pediatrics, Perinatology and Child Health, Nutrition and Dietetics and Health. According to data from OpenAlex, Frida Kasteng has authored 22 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 7 papers in Nutrition and Dietetics and 5 papers in Health. Recurrent topics in Frida Kasteng's work include Global Maternal and Child Health (8 papers), Child Nutrition and Water Access (7 papers) and Vaccine Coverage and Hesitancy (5 papers). Frida Kasteng is often cited by papers focused on Global Maternal and Child Health (8 papers), Child Nutrition and Water Access (7 papers) and Vaccine Coverage and Hesitancy (5 papers). Frida Kasteng collaborates with scholars based in Sweden, United Kingdom and United States. Frida Kasteng's co-authors include Karin Källander, Anna Vassall, Jonas Lundkvist, Karin Sennfält, Peter Lindgren, Jan W. Eriksson, Christer Svedman, Patrik Sobocki, Martin Erlanson and Mayur M. Amonkar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Frida Kasteng

22 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frida Kasteng Sweden 12 145 109 67 62 60 22 395
Heather Pauls United States 14 76 0.5× 86 0.8× 50 0.7× 33 0.5× 52 0.9× 23 458
Ursula Ellis Canada 13 53 0.4× 111 1.0× 56 0.8× 24 0.4× 95 1.6× 38 467
Son Nam Nguyen United States 9 107 0.7× 161 1.5× 33 0.5× 73 1.2× 117 1.9× 18 579
Maxwell Birger United States 12 172 1.2× 142 1.3× 43 0.6× 106 1.7× 86 1.4× 14 571
Gustavo Nigenda Mexico 12 135 0.9× 150 1.4× 19 0.3× 59 1.0× 68 1.1× 41 461
Miguel Ángel Lezana Mexico 8 159 1.1× 190 1.7× 41 0.6× 105 1.7× 62 1.0× 15 448
Azmi Mohamed Nahar Malaysia 7 84 0.6× 93 0.9× 21 0.3× 71 1.1× 84 1.4× 11 439
Asal M. Johnson United States 10 45 0.3× 193 1.8× 31 0.5× 82 1.3× 243 4.0× 18 661
Marta Rovery de Souza Brazil 14 86 0.6× 207 1.9× 15 0.2× 41 0.7× 127 2.1× 40 468
Arpita Chattopadhyay United States 13 38 0.3× 272 2.5× 17 0.3× 199 3.2× 36 0.6× 37 687

Countries citing papers authored by Frida Kasteng

Since Specialization
Citations

This map shows the geographic impact of Frida Kasteng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frida Kasteng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frida Kasteng more than expected).

Fields of papers citing papers by Frida Kasteng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frida Kasteng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frida Kasteng. The network helps show where Frida Kasteng may publish in the future.

Co-authorship network of co-authors of Frida Kasteng

This figure shows the co-authorship network connecting the top 25 collaborators of Frida Kasteng. A scholar is included among the top collaborators of Frida Kasteng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frida Kasteng. Frida Kasteng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soremekun, Seyi, Karin Källander, Raghu Lingam, et al.. (2023). Improving outcomes for children with malaria, diarrhoea and pneumonia in Mozambique: A cluster randomised controlled trial of the inSCALE technology innovation. SHILAP Revista de lepidopterología. 2(6). e0000235–e0000235. 7 indexed citations
2.
Källander, Karin, Seyi Soremekun, Daniel Strachan, et al.. (2023). Improving community health worker treatment for malaria, diarrhoea, and pneumonia in Uganda through inSCALE community and mHealth innovations: A cluster randomised controlled trial. SHILAP Revista de lepidopterología. 2(6). e0000217–e0000217. 3 indexed citations
3.
Batura, Neha, Frida Kasteng, Karin Källander, et al.. (2022). Costs of treating childhood malaria, diarrhoea and pneumonia in rural Mozambique and Uganda. Malaria Journal. 21(1). 239–239. 5 indexed citations
4.
Albala, Sarah, Frida Kasteng, Arne H. Eide, & Rainer Kattel. (2021). Scoping review of economic evaluations of assistive technology globally. Assistive Technology. 33(sup1). 50–67. 11 indexed citations
5.
Soremekun, Seyi, Frida Kasteng, Raghu Lingam, et al.. (2018). Variation in the quality and out-of-pocket cost of treatment for childhood malaria, diarrhoea, and pneumonia: Community and facility based care in rural Uganda. PLoS ONE. 13(11). e0200543–e0200543. 18 indexed citations
6.
Kasteng, Frida, Simon Cousens, Sophie Sarrassat, et al.. (2018). Cost-effectiveness and economies of scale of a mass radio campaign to promote household life-saving practices in Burkina Faso. BMJ Global Health. 3(4). e000809–e000809. 19 indexed citations
7.
Sarrassat, Sophie, Jennifer Hollowell, Pieter Remes, et al.. (2018). Modelling the effect of a mass radio campaign on child mortality using facility utilisation data and the Lives Saved Tool (LiST): findings from a cluster randomised trial in Burkina Faso. BMJ Global Health. 3(4). e000808–e000808. 17 indexed citations
8.
Borgermans, Liesbeth, Loraine Busetto, Jorid Kalseth, et al.. (2017). How to Improve Integrated Care for People with Chronic Conditions: Key Findings from EU FP-7 Project INTEGRATE and Beyond. International Journal of Integrated Care. 17(4). 7–7. 50 indexed citations
9.
Kasteng, Frida, et al.. (2016). An overview of payment mechanisms and contractual models to support patient-centred care integration. International Journal of Integrated Care. 16(6). 337–337. 3 indexed citations
10.
11.
12.
Kasteng, Frida, et al.. (2015). Valuing the work of unpaid community health workers and exploring the incentives to volunteering in rural Africa. Health Policy and Planning. 31(2). 205–216. 62 indexed citations
13.
Soremekun, Seyi & Frida Kasteng. (2013). THE INSCALE BASELINE SURVEY UGANDA. 1 indexed citations
14.
Kasteng, Frida, Jan W. Eriksson, Karin Sennfält, & Peter Lindgren. (2011). Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. Acta Psychiatrica Scandinavica. 124(3). 214–225. 34 indexed citations
15.
Kim, Kun, Mayur M. Amonkar, Dan Högberg, & Frida Kasteng. (2011). Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK. Head & Neck Oncology. 3(1). 47–47. 27 indexed citations
16.
Wilking, N., Jonas Bergh, B Jönsson, & Frida Kasteng. (2010). Breast cancer patients access to screening, radiotherapy, and cancer drugs in 18 European, Asian, and Latin American countries.. Journal of Clinical Oncology. 28(15_suppl). 612–612. 4 indexed citations
17.
Wilking, N., et al.. (2009). A review of breast cancer care and outcomes in 18 countries in Europe, Asia, and Latin America. Amsterdam UMC (VU Amsterdam) - Institutional Repository. 4 indexed citations
18.
Kasteng, Frida, Martin Erlanson, Hans Hagberg, et al.. (2008). Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden. Acta Oncologica. 47(6). 1029–1036. 37 indexed citations
19.
Kasteng, Frida, Patrik Sobocki, Christer Svedman, & Jonas Lundkvist. (2007). Economic evaluations of leukemia: A review of the literature. International Journal of Technology Assessment in Health Care. 23(1). 43–53. 30 indexed citations
20.
Kasteng, Frida, Rudolf Stadler, Gunnar Wagenius, & Jonas Lundkvist. (2007). PCN27 COST-EFFECTIVENESS OF HUMAN INTERFERON-ALPHAAS ADJUVANT TREATMENT FOR PATIENTS WITH RESECTED CUTANEOUS MALIGNANT MELANOMA IN STAGE MB & III. Value in Health. 10(6). A330–A330. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather Pauls Breakdown of academic impact, for papers by Ursula Ellis Breakdown of academic impact, for papers by Son Nam Nguyen Breakdown of academic impact, for papers by Maxwell Birger Breakdown of academic impact, for papers by Gustavo Nigenda Breakdown of academic impact, for papers by Miguel Ángel Lezana Breakdown of academic impact, for papers by Azmi Mohamed Nahar Breakdown of academic impact, for papers by Asal M. Johnson Breakdown of academic impact, for papers by Marta Rovery de Souza Breakdown of academic impact, for papers by Arpita Chattopadhyay
Rankless by CCL
2026